- Did you mean
- sans-cov-2
Search results - 13 results
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
Chloé Wyndham-Thomas; Koen Blot; Lucy Catteau Source: Euro Surveill, Volume 28, Issue 26 (2023) Keywords: Belgium COVID-19 COVID-19 Vaccines Hospitalization Humans SARS-CoV-2 Vaccine Efficacy Abstract: ...
Homologous versus heterologous prime-boost COVID-19 vaccination: impact on clinical severity of Omicron among hospitalized COVID-19 patients in Belgium
SARS-CoV-2 Omicron infection among hospitalized patients in Belgium, and if this effect is homogenous across different Omicron sub-lineages. Methods Observational data from existing national surveillance ...
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
Publication Type: Peer reviewed scientific article Authors: Toon Braeye; Lucy Catteau; Ruben Brondeel; Joris Van Loenhout; Kristiaan Proesmans; Laura Cornelissen; Herman Van Oyen; Veerle Stouten; Pierre Hubin; Matthieu Billuart; Achille Djiena; Romain Mah ...
Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium.
Weyenbergh; Lucy Catteau; Simon Dellicour Source: Viruses, Volume 14, Issue 6 (2022) Keywords: Aged Belgium COVID-19 COVID-19 Vaccines Hospitalization Humans SARS-CoV-2 Vaccination Abstract: The national ...
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
over Bayes Theorem Belgium BNT162 Vaccine Contact Tracing COVID-19 Humans middle aged RNA, Viral SARS-CoV-2 Vaccination Vaccine Efficacy vaccines Abstract: BACKGROUND: During the first half of 2021, we ...
Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium.
Wyndham-Thomas; Lucy Catteau Source: Viruses, Volume 14, Issue 4 (2022) Keywords: Ad26COVS1 Adult Belgium BNT162 Vaccine COVID-19 COVID-19 Vaccines Humans incidence Prospective Studies Risk Factors SARS-CoV-2 ...
Risk factors associated with breakthrough SARS-CoV-2 infections after vaccination: a prospective cohort study in Belgium
Publication Type: Scientific poster, presentation or proceeding Authors: Veerle Stouten; Pierre Hubin; Freek Haarhuis; Joris Van Loenhout; Matthieu Billuart; Ruben Brondeel; Toon Braeye; Herman Van Oyen; Chloé Wyndham-Thomas; Lucy Catteau Source: (2022) H ...
Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme.
Immunoglobulin A Immunoglobulin G Immunoglobulin M Male Phosphoproteins SARS-CoV-2 Sensitivity and Specificity Spike Glycoprotein, Coronavirus Abstract: We report on sample IS /17575 since it generated highly ...
Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.
recruited in NH in Belgium before immunization with two doses of 30µg BNT162 b2 mRNA vaccine at day 0 and day 21. Binding antibodies (Ab) to SARS-CoV-2 receptor binding domain (RBD), spike domains S1 and S2, ...
Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants
silico approach. Previously, we reported some mismatches between the oligonucleotides of publicly available RT-qPCR assays and SARS-CoV-2 genomes collected from GISAID and NCBI, potentially impacting ...